What is the current Price Target for the ESSA Pharma Inc stock?

The average ESSA Pharma Inc target price is $2.00. This is 26.58% higher than the current stock price. 1 Analyst has issued a ESSA Pharma Inc price target 2026.

How high will the ESSA Pharma Inc stock rise?

No reliable answer can be given as to how high the ESSA Pharma Inc stock will rise. The performance of stocks, including the ESSA Pharma Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the ESSA Pharma Inc stock today?

The performance of ESSA Pharma Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the ESSA Pharma Inc stock fall?

The decline in ESSA Pharma Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

ESSA Pharma Inc Forecast, price target & analysts

$1.62

2.22% today

Nasdaq, Apr 03, 06:44 pm CET

ISIN

CA29668H7085

Symbol

EPIX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

ESSA Pharma Inc Target price 2025 - Analyst rating & recommendation

ESSA Pharma Inc Classifications & Recommendation:

Hold

100%

ESSA Pharma Inc Price Target

Target Price	$2.00
Price	$1.58
Potential	26.58% register free of charge
Number of Estimates	1

	1 Analyst has issued a ESSA Pharma Inc price target 2026. The average ESSA Pharma Inc target price is $2.00. This is 26.58% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 0 Analysts recommend ESSA Pharma Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the ESSA Pharma Inc stock has an average upside potential 2026 of 26.58% register free of charge . Most analysts recommend the ESSA Pharma Inc stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Sep '24	2025 Estimates
Earnings Per Share $	-0.64	-0.71
	6.67%	10.94%
P/E		negative

1 Analysts have issued a ESSA Pharma Inc forecast for earnings per share. The average ESSA Pharma Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.64	6.67%
2025	$-0.71 10.94% Unlock
2026	$-0.49 30.99% Unlock
2027	$-0.49 0.00% Unlock
2028	$-0.48 2.04% Unlock

Current	-2.25	84.49%
2025	-2.23 0.89% Unlock
2026	-3.22 44.39% Unlock
2027	-3.22 0.00% Unlock
2028	-3.29 2.17% Unlock

ESSA Pharma Inc...

Current ESSA Pharma Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Oppenheimer	Locked ➜ Locked	Locked	Nov 04 2024
Piper Sandler	Locked ➜ Locked	Locked	Nov 04 2024
Jones Trading	Locked ➜ Locked	Locked	Nov 01 2024

Analyst Rating	Date
Locked Oppenheimer: Locked ➜ Locked	Nov 04 2024
Locked Piper Sandler: Locked ➜ Locked	Nov 04 2024
Locked Jones Trading: Locked ➜ Locked	Nov 01 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now